Details of the Drug
General Information of Drug (ID: DMN80XD)
Drug Name |
PT-313
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Thiourea, N-(4-methyl-2-thiazolyl)-N'-(2-phenylethyl)-; 149485-00-7; PETT Analog 37; PT-313; AC1MHDKO; SCHEMBL8885589; CHEMBL254628; BDBM1870; DTXSID50164282; ZINC13744891; AKOS030011211; 1-Phenethyl-3-(4-methyl-2-thiazolyl)thiourea; 1-(4-methylthiazol-2-yl)-3-phenethyl-thiourea; N-(2-Phenethyl)-N -(2-(4-methylthiazolyl))thiourea; 1-(4-methyl-1,3-thiazol-2-yl)-3-phenethylthiourea
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 277.4 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 3.2 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References